Iterum Therapeutics Plc (ITRM) is ready to report earnings on August 12. Lets look at the stock.
Share price moves can have an impact on existing shareholder sentiment. As of August 04 shares of ITRM are trading at $0.2315. Over the last 52-week period, the price is down -71.03%. This kind of move may lead shareholders to be bearish.
Analysts think Iterum Therapeutics Plc will clock in with an EPS (earnings per share) of around -$0.34. Over the last 90 days, analysts have lowered estimates twice, also a bearish sign.
If you're a bull you'll primarily care about three things. The first is that the reported EPS beat analysts estimates. The second is that the beat is on higher than expected revenues. Third, that the company guides analysts to robust growth going forward. If all check out, the stock should react accordingly.
There are two primary things that ITRM bears will be concerned with. The first is that the reported EPS underperformed the estimates of analysts. Stocks respond unfavorably to that news. The second is that the report outlines a negative growth story for the stock in the coming quarters.
If you're new to playing earnings reports, it's important to be aware that sometimes the majority of a stock's price movement can be caused by a change in the analysts' estimates based on the Q&A from the conference call with management discussing the earnings report, rather than from the earnings report itself. The more of these moves you watch, the better you'll recognize the signs over time.